Method to estimate the approximate samples size that yield a certain number of significant GWAS signals in polygenic traits

Genetic Epidemiology
Silviu-Alin Bacanu, Kenneth S Kendler

Abstract

To argue for increased sample collection for disorders without significant findings, researchers resorted to plotting, for multiple traits, the number of significant findings as a function of the sample size. However, for polygenic traits, the prevalence of the disorder confounds the relationship between the number of significant findings and the sample size. To adjust the number of significant findings for prevalence, we develop a method that uses the expected noncentrality of the contrast between liabilities of cases and controls. We empirically find that, when compared to the sample size, this measure is a better predictor of number of significant findings. Even more, we show that the sample size effect on the number of signals is explained by the noncentrality measure. Finally, we provide an R script to estimate the required sample size (noncentrality) needed to yield a prespecified number of significant findings, along with the converse.

References

May 27, 2005·PLoS Medicine·Sukanta SahaJohn McGrath
Apr 28, 2007·Science·UNKNOWN Diabetes Genetics Initiative of Broad Institute of Harvard and MIT, Lund University, and Novartis Institutes of BioMedical RShaun Purcell
Jun 8, 2007·Nature·UNKNOWN Wellcome Trust Case Control Consortium
Apr 9, 2008·Nature Genetics·Michael N WeedonTimothy M Frayling
Nov 18, 2008·Human Molecular Genetics·Sergio E BaranziniJorge R Oksenberg
Dec 17, 2008·Nature Genetics·Cristen J WillerUNKNOWN Genetic Investigation of ANthropometric Traits Consortium
Nov 17, 2009·Nature Genetics·Javier Simón-SánchezThomas Gasser
Jun 24, 2010·Human Molecular Genetics·Dermot P B McGovernUNKNOWN International IBD Genetics Consortium
Oct 12, 2010·Nature Genetics·Elizabeth K SpeliotesRuth J F Loos
Oct 19, 2010·Nature Genetics·Philip E StuartJames T Elder
Apr 21, 2011·Schizophrenia Bulletin·Yunjung KimPatrick F Sullivan
Sep 20, 2011·Nature Genetics·UNKNOWN Psychiatric GWAS Consortium Bipolar Disorder Working Group
Dec 16, 2011·The Journal of Investigative Dermatology·Eva EllinghausAndre Franke
Jan 17, 2012·American Journal of Human Genetics·Peter M VisscherJian Yang
Apr 5, 2012·Molecular Psychiatry·UNKNOWN Major Depressive Disorder Working Group of the Psychiatric GWAS ConsortiumPatrick F Sullivan
Jun 5, 2013·American Journal of Human Genetics·UNKNOWN International Multiple Sclerosis Genetics Consortium
Aug 27, 2013·Nature Genetics·Stephan RipkePatrick F Sullivan
Jan 7, 2014·Nature·Yukinori OkadaRobert M Plenge
Feb 11, 2014·Nature Genetics·UNKNOWN DIAbetes Genetics Replication And Meta-analysis (DIAGRAM) ConsortiumAndrew P Morris
May 29, 2014·Nature Neuroscience·Jacob GrattenPeter M Visscher
Jul 25, 2014·Nature·UNKNOWN Schizophrenia Working Group of the Psychiatric Genomics Consortium
Feb 13, 2015·Nature·Dmitry ShunginKaren L Mohlke
Feb 13, 2015·Nature·Adam E LockeElizabeth K Speliotes

❮ Previous
Next ❯

Citations

Oct 3, 2018·Alcoholism, Clinical and Experimental Research·Alexis C EdwardsMarc A Schuckit
Mar 21, 2020·Animals : an Open Access Journal From MDPI·Naomi SykesGreger Larson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved